TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
Clinical trial NCT03884556 · COMPLETED
Trial details
- NCT number
- NCT03884556
- Sponsor
- Trishula Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-10
- Primary completion
- 2022-11-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.